Dominic Smethurst
Chief Tech/Sci/R&D Officer at CORBUS PHARMACEUTICALS HOLDINGS, INC.
Net worth: 2 M $ as of 2024-04-29
Dominic Smethurst active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2024-02-27 | - |
| Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Career history of Dominic Smethurst
Former positions of Dominic Smethurst
| Companies | Position | Start | End |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2020-06-30 | 2023-03-30 |
| THOR MEDICAL | Chief Tech/Sci/R&D Officer | 2020-03-22 | 2020-08-09 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Chief Tech/Sci/R&D Officer | 2016-08-31 | 2018-08-31 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Private Equity Investor | - | - |
| ICON PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
| BERGENBIO ASA | Chief Tech/Sci/R&D Officer | 2019-03-12 | - |
Training of Dominic Smethurst
| Christ's College (United Kingdom) | Graduate Degree |
| University of Cambridge | Undergraduate Degree |
Statistics
International
| United Kingdom | 8 |
| Norway | 3 |
| Ireland | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| BERGENBIO ASA | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Faculty of Pharmaceutical Medicine | |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Health Technology |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
- Stock Market
- Insiders
- Dominic Smethurst
- Experience
